Pharmaceutical Research is categorized under Commercial Medical Research in Dallas, TX and active since 1991.
Pharmaceutical Research was established in 1991, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 6219993 by the NAICS.
If you are seeking more information, feel free to contact Gary Gross, Owner at the company’s single location by writing to 5499 Glen Lakes Drive # 200, Dallas, Texas TX 75231 or by phoning (214) 361-5555. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Pharmaceutical Research |
| Contact Person: | Gary Gross, Owner |
| Address: | 5499 Glen Lakes Drive # 200, Dallas, Texas 75231 |
| Phone Number: | (214) 361-5555 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1991 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 6219993 |
| Share This Business: |
Pharmaceutical Research was started in 1991 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 6219993. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Gary Gross, Owner for inquiries that concern Pharmaceutical Research by calling the company number (214) 361-5555, as your correspondence is most welcome. Additionally, the physical location of the single location of Pharmaceutical Research can be found at the coordinates 32.88341,-96.7657 as well as the street address 5499 Glen Lakes Drive # 200 in Dallas, Texas 75231.
For its online presence, you may visit Pharmaceutical Research’s website at and engage with its social media outlets through on Twitter and on Facebook.